Skip to main content
Clinical Trials/ISRCTN10996089
ISRCTN10996089
Active, not recruiting
未知

Probing molecular signatures in human lung disease using novel optical technologies; Lung Spy

niversity of Edinburgh0 sites80 target enrollmentApril 11, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
ung disease including infection inflammation and cancer
Sponsor
niversity of Edinburgh
Enrollment
80
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2022
End Date
April 1, 2027
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Edinburgh

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \= 16 years
  • 2\. Deemed suitable for bronchoscopy and study procedures by attending consultant (including consideration of routine medical interventions)
  • 3\. Capacity to provide informed consent
  • 4\. Readily accessible target areas with bronchoscopy (or navigational bronchoscopy where clinically indicated) and fibre based endoscopy
  • 5\. Complies with sponsor co\-enrolment criteria
  • 6\. Undergoing a clinically indicated bronchoscopy or agrees to undergo a research only bronchoscopy for the purpose of the study

Exclusion Criteria

  • 1\. History of anaphylaxis
  • 2\. Documented history of allergy to fluorescein
  • 3\. Women (of childbearing potential) who are pregnant or are breastfeeding
  • 4\. Currently prescribed drugs that cause increased autofluorescence in the lung, specifically amiodarone and methotrexate

Outcomes

Primary Outcomes

Not specified

Similar Trials